Beyond Prostate-Specific Antigen Response: Could 18 F-FDG PET Refine Patient Selection for Rechallenge with [ 177 Lu]Lu-PSMA-617?

TO THE EDITOR: I read with great interest the recently published RE-LuPSMA protocol by Nikitas et al. describing a prospective phase 2 study evaluating retreatment with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer who previously benefited from prostate-

Authors

Publication Details

Journal
Journal of Nuclear Medicine
Published
2026-10-29
DOI
https://doi.org/10.2967/jnumed.126.273292
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Prostate-Specific Antigen Response: Could 18 F-FDG PET Refine Patient Selection for Rechallenge with [ 177 Lu]Lu-PSMA-617?

Alev Çinar
5 links
Journal of Nuclear Medicine
Radiopharmaceutical Chemistry and Applications
article

Beyond Prostate-Specific Antigen Response: Could 18 F-FDG PET Refine Patient Selection for Rechallenge with [ 177 Lu]Lu-PSMA-617?

Alev Çinar
article en

Abstract

TO THE EDITOR: I read with great interest the recently published RE-LuPSMA protocol by Nikitas et al. describing a prospective phase 2 study evaluating retreatment with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer who previously benefited from prostate-

Journal of Nuclear Medicine
Good health and well-being
Openalex Percentile: Top 13%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Beyond Prostate-Specific Antigen Response: Could 18 F-FDG PET Refine Patient Selection for Rechallenge with [ 177 Lu]Lu-PSMA-617? — Alev Çinar · Journal of Nuclear Medicine (2026) | TGRS Research Map | TGRS